A048260 Stock Overview
Osstem Implant Co., Ltd. manufactures and supplies dental implants worldwide.
Osstem Implant Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||₩115,300.00|
|52 Week High||₩146,500.00|
|52 Week Low||₩90,700.00|
|1 Month Change||-13.89%|
|3 Month Change||17.06%|
|1 Year Change||-13.31%|
|3 Year Change||188.97%|
|5 Year Change||65.19%|
|Change since IPO||576.25%|
Recent News & Updates
|A048260||KR Medical Equipment||KR Market|
Return vs Industry: A048260 exceeded the KR Medical Equipment industry which returned -28.6% over the past year.
Return vs Market: A048260 exceeded the KR Market which returned -28.7% over the past year.
|A048260 Average Weekly Movement||8.2%|
|Medical Equipment Industry Average Movement||6.0%|
|Market Average Movement||5.9%|
|10% most volatile stocks in KR Market||10.6%|
|10% least volatile stocks in KR Market||3.6%|
Stable Share Price: A048260 is more volatile than 75% of KR stocks over the past 3 months, typically moving +/- 8% a week.
Volatility Over Time: A048260's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
Osstem Implant Co., Ltd. manufactures and supplies dental implants worldwide. It provides dental implant systems, dental equipment and supplies, and integrated solutions and cephalometric analysis software products for dental clinics, as well as dental training services. The company was founded in 1997 and is headquartered in Seoul, South Korea.
Osstem Implant Fundamentals Summary
|A048260 fundamental statistics|
Is A048260 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|A048260 income statement (TTM)|
|Cost of Revenue||₩367.23b|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||3.07k|
|Net Profit Margin||4.40%|
How did A048260 perform over the long term?See historical performance and comparison
0.3%Current Dividend Yield
Is A048260 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 2/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for A048260?
Other financial metrics that can be useful for relative valuation.
|What is A048260's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does A048260's PE Ratio compare to its peers?
|A048260 PE Ratio vs Peers|
|Company||PE||Estimated Growth||Market Cap|
A048260 Osstem Implant
Price-To-Earnings vs Peers: A048260 is expensive based on its Price-To-Earnings Ratio (37.5x) compared to the peer average (13.6x).
Price to Earnings Ratio vs Industry
How does A048260's PE Ratio compare vs other companies in the KR Medical Equipment Industry?
Price-To-Earnings vs Industry: A048260 is expensive based on its Price-To-Earnings Ratio (37.5x) compared to the KR Medical Equipment industry average (10.5x)
Price to Earnings Ratio vs Fair Ratio
What is A048260's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||37.5x|
|Fair PE Ratio||35x|
Price-To-Earnings vs Fair Ratio: A048260 is expensive based on its Price-To-Earnings Ratio (37.5x) compared to the estimated Fair Price-To-Earnings Ratio (35x).
Share Price vs Fair Value
What is the Fair Price of A048260 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: A048260 (₩115300) is trading below our estimate of fair value (₩466059.66)
Significantly Below Fair Value: A048260 is trading below fair value by more than 20%.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.
Discover undervalued companies
How is Osstem Implant forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?
Future Growth Score5/6
Future Growth Score 5/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: A048260's forecast earnings growth (38.2% per year) is above the savings rate (3.6%).
Earnings vs Market: A048260's earnings (38.2% per year) are forecast to grow faster than the KR market (17.3% per year).
High Growth Earnings: A048260's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: A048260's revenue (16.5% per year) is forecast to grow faster than the KR market (9.9% per year).
High Growth Revenue: A048260's revenue (16.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: A048260's Return on Equity is forecast to be high in 3 years time (39.2%)
Discover growth companies
How has Osstem Implant performed over the past 5 years?
Past Performance Score2/6
Past Performance Score 2/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: A048260 has high quality earnings.
Growing Profit Margin: A048260's current net profit margins (4.4%) are lower than last year (21.1%).
Past Earnings Growth Analysis
Earnings Trend: A048260's earnings have grown significantly by 36.8% per year over the past 5 years.
Accelerating Growth: A048260's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: A048260 had negative earnings growth (-72.9%) over the past year, making it difficult to compare to the Medical Equipment industry average (12.1%).
Return on Equity
High ROE: A048260's Return on Equity (16.4%) is considered low.
Discover strong past performing companies
How is Osstem Implant's financial position?
Financial Health Score5/6
Financial Health Score 5/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: A048260's short term assets (₩674.3B) do not cover its short term liabilities (₩933.1B).
Long Term Liabilities: A048260's short term assets (₩674.3B) exceed its long term liabilities (₩71.0B).
Debt to Equity History and Analysis
Debt Level: A048260's net debt to equity ratio (36.9%) is considered satisfactory.
Reducing Debt: A048260's debt to equity ratio has reduced from 150% to 148.9% over the past 5 years.
Debt Coverage: A048260's debt is well covered by operating cash flow (44.1%).
Interest Coverage: A048260's interest payments on its debt are well covered by EBIT (12.1x coverage).
Discover healthy companies
What is Osstem Implant current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Cash Flow Coverage
Current Dividend Yield
Dividend Yield vs Market
|Osstem Implant Dividend Yield vs Market|
|Company (Osstem Implant)||0.3%|
|Market Bottom 25% (KR)||1.1%|
|Market Top 25% (KR)||3.6%|
|Industry Average (Medical Equipment)||2.0%|
|Analyst forecast in 3 Years (Osstem Implant)||0.3%|
Notable Dividend: A048260's dividend (0.26%) isn’t notable compared to the bottom 25% of dividend payers in the KR market (1.14%).
High Dividend: A048260's dividend (0.26%) is low compared to the top 25% of dividend payers in the KR market (3.54%).
Stability and Growth of Payments
Stable Dividend: A048260 is not paying a notable dividend for the KR market, therefore no need to check if payments are stable.
Growing Dividend: A048260 is not paying a notable dividend for the KR market, therefore no need to check if payments are increasing.
Earnings Payout to Shareholders
Earnings Coverage: A048260 is not paying a notable dividend for the KR market.
Cash Payout to Shareholders
Cash Flow Coverage: A048260 is not paying a notable dividend for the KR market.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Tae-Kwan Um (59 yo)
Mr. Tae-Kwan Um served as Senior Managing Director of Osstem Implant Co., Ltd. and served as its Managing Director. He serves as Chief Executive Officer at Osstem Implant Co., Ltd.Mr. Um served as Chief o...
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
|Owner Type||Number of Shares||Ownership Percentage|
|Employee Share Scheme||968||0.007%|
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
|Ownership||Name||Shares||Current Value||Change %||Portfolio %|
Osstem Implant Co., Ltd.'s employee growth, exchange listings and data sources
- Name: Osstem Implant Co., Ltd.
- Ticker: A048260
- Exchange: KOSDAQ
- Founded: 1997
- Industry: Health Care Equipment
- Sector: Healthcare
- Implied Market Cap: ₩1.569t
- Shares outstanding: 13.61m
- Website: https://en.osstem.com
Number of Employees
- Osstem Implant Co., Ltd.
- 3, Magokjungang 12-ro
- South Korea
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|A048260||KOSDAQ (KOSDAQ)||Yes||Common Stock||KR||KRW||Feb 2007|
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/09/30 00:00|
|End of Day Share Price||2022/09/30 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.